Targeting Lipoprotein Lipase in Neurodegenerative Disease | Kimberley D Bruce, PhD
https://medschool.cuanschutz.edu/medicine | University of Colorado | Department of Medicine's April 14 Research and Innovation Conference—"Targeting Lipoprotein Lipase in Neurodegenerative Disease" with Kimberley D. Bruce, PhD, assistant professor of medicine from the Division of Endocrinology, Metabolism and Diabetes
Видео Targeting Lipoprotein Lipase in Neurodegenerative Disease | Kimberley D Bruce, PhD канала University of Colorado | Department of Medicine
Видео Targeting Lipoprotein Lipase in Neurodegenerative Disease | Kimberley D Bruce, PhD канала University of Colorado | Department of Medicine
Показать
Комментарии отсутствуют
Информация о видео
19 апреля 2022 г. 1:12:07
00:26:34
Другие видео канала
CU Anschutz Department of Medicine COVID Expert ForumGrand Rounds 4/22/2020"Rationing Dialysis" presented by Shrey PurohitGenomic medicine and personalized cancer care for advanced precision therapeuticsGrand Rounds 6/17/19Are PICCs the Central Venous Catheter of the Future? – Vineet Chopra, MBBS, MD, MScSo Whatcha Sayin’?: Pandemic Lessons on Communication | Taison D. Bell, MDNovel Methods to Improve Identification of Hereditary Cancer Syndromes | Swati G. Patel, MD, MSComplement and the Kidney | Joshua M. Thurman, MDDOM Grand Rounds | Benjamin Click, MDDOM Grand Rounds | The 2024 Blount LectureshipBetter Together Physician Coaching: Preventing and Mitigating Burnout in Women ResidentsAdvances in HIV Pre-Exposure Prophylaxis (PrEP) | Katherine Frasca, MDA Physical Activity Support Program for Adults with Overweight or Obesity: Preliminary FindingsCAR T-Cells and Cancer Immunogenetics—Towards Personalized Therapies | Drs. Smith and FryDOM Grand Rounds | "Prescriptions in Motion: Revolutionizing Delivery of Healthcare to Community"Immunotherapy in Lymphomas – the Present and the Future | Manali Kamdar, MDAdult Acute Lymphoblastic Leukemia Program at CU Anschutz | Marc S. Schwartz, MDMechanisms of Cardiometabolic Stress & Novel Opportunities for Disease-Modifying TherapiesGrand Rounds 5/26/2021